Reliability of oxidative stress biomarkers in hemodialysis patients: A comparative study

Clinical Chemistry and Laboratory Medicine

Volumn 45, Issue 9, 2007, Pages 1211-1218

  Palleschi, Simonetta ^a   De Angelis, Sandro ^b   Diana, Loretta ^a   Rossi, Barbara ^a   Papa, Vincenza ^a   Severini, Giancarlo ^a   Splendiani, Giorgio ^b  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Antioxidants; Chronic kidney failure; Lipid peroxides; Malondialdehyde; Oxidative stress; Renal dialysis; Vitamins

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BIOLOGICAL MARKER; HYDROPEROXIDE; MALONALDEHYDE; RETINOL; THIOL DERIVATIVE; URIC ACID;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; RELIABILITY; RENAL REPLACEMENT THERAPY;

ADULT; AGED; ANTIOXIDANTS; BIOLOGICAL MARKERS; CHEMISTRY, CLINICAL; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; RENAL DIALYSIS; REPRODUCIBILITY OF RESULTS; UREMIA;

EID: 34548563969     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2007.266     Document Type: Article

References (39)

1. Young IS, Woodside JV. Antioxidants in health and disease. J Clin Pathol 2001;54:176-86.
2. Galle J. Oxidative stress in chronic renal failure. Nephrol Dial Transplant 2001;16:2135-7.
3. Vaziri ND. Oxidative stress in uremia: nature, mechanisms, and potential consequences. Semin Nephrol 2004;24:469-73.
4. Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C, Zoccali C. Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant 2003;18:1272-80.
5. Muller C, Eisenbrand G, Gradinger M, Rath T, Albert FW, Vienken J, et al. Effects of hemodialysis, dialyser type and iron infusion on oxidative stress in uremic patients. Free Radic Res 2004;38:1093-100.
6. Erdogan C, Unlucerci Y, Turkmen A, Kuru A, Cetin O, Bekpinar S. The evaluation of oxidative stress in patients with chronic renal failure. Clin Chim Acta 2002;322:157-61.
7. Gerardi G, Usberti M, Martini G, Albertini A, Sugherini L, Pompella A, et al. Plasma total antioxidant capacity in hemodialyzed patients and its relationships to other biomarkers of oxidative stress and lipid peroxidation. Clin Chem Lab Med 2002;40:104-10.
8. Walter MF, Blumberg JB, Dolnikowski GG, Handelman GJ. Streamlined F2-isoprostane analysis in plasma and urine with high-performance liquid chromatography and gas chromatography/mass spectroscopy. Anal Biochem 2000;280:73-9.
9. Morena M, Cristol JP, Bosc JY, Tetta C, Forret G, Leger CL, et al. Convective and diffusive losses of vitamin C during haemodiafiltration session: a contributive factor to oxidative stress in haemodialysis patients. Nephrol Dial Transplant 2002;17:422-7.
10. Usberti M, Gerardi G, Bufano G, Tira P, Micheli A, Albertini A, et al. Effects of erythropoietin and vitamin E-modified membrane on plasma oxidative stress markers and anemia of hemodialyzed patients. Am J Kidney Dis 2002;40:590-9.
11. Alhamdani MS. Impairment of glutathione biosynthetic pathway in uraemia and dialysis. Nephrol Dial Transplant 2005;20:124-8.
12. Wiswedel I, Hirsch D, Carluccio F, Hampl H, Siems W. F2-isoprostanes as biomarkers of lipid peroxidation in patients with chronic renal failure. Biofactors 2005;24:201-8.
13. Ross MA. Determination of ascorbic acid and uric acid in plasma by high-performance liquid chromatography. J Chromatogr B Biomed Appl 1994;657:197-200.
14. Nierenberg DW, Lester DC. Determination of vitamins A and E in serum and plasma using a simplified clarification method and high-performance liquid chromatography. J Chromatogr 1985;345:275-84.
15. Fukunaga K, Yoshida M, Nakazono N. A simple, rapid, highly sensitive and reproducible quantification method for plasma malondialdehyde by high-performance liquid chromatography. Biomed Chromatogr 1998;12:300-3.
16. Vassalle C, Masini S, Carpeggiani C, L'Abbate A, Boni C, Zucchelli GC. In vivo total antioxidant capacity: comparison of two different analytical methods. Clin Chem Lab Med 2004;42:84-9.
17. Vassalle C, Boni C, Di CP, Ndreu R, Zucchelli GC. Automation and validation of a fast method for the assessment of in vivo oxidative stress levels. Clin Chem Lab Med 2006;44:1372-5.
18. Ford L, Farr J, Morris P, Berg J. The value of measuring serum cholesterol-adjusted vitamin E in routine practice. Ann Clin Biochem 2006;43:130-4.
19. Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of antioxidant power: the FRAP assay. Anal Biochem 1996;239:70-6.
20. Nguyen-Khoa T, Massy ZA, Witko-Sarsat V, Thevenin M, Touam M, Lambrey G, et al. Critical evaluation of plasma and LDL oxidant-trapping potential in hemodialysis patients. Kidney Int 1999;56:747-53.
21. Galli F, Floridi AG, Floridi A, Buoncristiani U. Accumulation of vitamin E metabolites in the blood of renal failure patients. Clin Nutr 2004;23:205-12.
22. Fischer MA, Gransier TJ, Beckers LM, Bekers O, Bast A, Haenen GR. Determination of the antioxidant capacity in blood. Clin Chem Lab Med 2005;43:735-40.
23. Cao G, Prior RL. Comparison of different analytical methods for assessing total antioxidant capacity of human serum. Clin Chem 1998;44:1309-15.
24. Kalousova M, Zima T, Tesar V, Sulkova S, Fialova L. Relationship between advanced glycoxidation end products, inflammatory markers/acute-phase reactants, and some autoantibodies in chronic hemodialysis patients. Kidney Int Suppl 2003;S62-4.
25. Dursun E, Ozben T, Suleymanlar G, Dursun B, Yakupoglu G. Effect of hemodialysis on the oxidative stress and antioxidants. Clin Chem Lab Med 2002;40:1009-13.
26. Witko-Sarsat V, Gausson V, Descamps-Latscha B. Are advanced oxidation protein products potential uremic toxins? Kidney Int Suppl 2003;S11-4.
27. Prakash M, Upadhya S, Prabhu R. Serum non-transferrin bound iron in hemodialysis patients not receiving intravenous iron. Clin Chim Acta 2005;360:194-8.
28. Daschner M, Lenhartz H, Botticher D, Schaefer F, Wollschlager M, Mehls O, et al. Influence of dialysis on plasma lipid peroxidation products and antioxidant levels. Kidney Int 1996;50:1268-72.
29. Prakash M, Upadhya S, Prabhu R. Protein thiol oxidation and lipid peroxidation in patients with uraemia. Scand J Clin Lab Invest 2004;64:599-604.
30. Andersson A, Jonasson T, Ohlin H, Lindgren A, Hultberg B. Vitamin supplementation normalizes total plasma homocysteine concentration but not plasma homocysteine redox status in patients with acute coronary syndromes and hyperhomocysteinemia. Clin Chem Lab Med 2002;40:554-8.
31. Lucchi L, Iannone A, Bergamini S, Stipo L, Perrone S, Uggeri S, et al. Comparison between hydroperoxides and malondialdehyde as markers of acute oxidative injury during hemodialysis. Artificial Organs 2005;29:832-7.
32. Siems W, Quast S, Peter D, Augustin W, Carluccio F, Grune T, et al. Oxysterols are increased in plasma of end-stage renal disease patients. Kidney Blood Press Res 2005;28:302-6.
33. Vaslaki L, Major L, Berta K, Karatson A, Misz M, Pethoe F, et al. On-line haemodiafiltration versus haemodialysis: stable haematocrit with less erythropoietin and improvement of other relevant blood parameters. Blood Purif 2006;24:163-73.
34. Lucchi L, Bergamini S, Iannone A, Perrone S, Stipo L, Olmeda F, et al. Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments. Artificial Organs 2005;29:67-72.
35. Jurek A, Turyna B, Kubit P, Klein A. LDL susceptibility to oxidation and HDL antioxidant capacity in patients with renal failure. Clin Biochem 2006;39:19-27.
36. Maggi E, Bellazzi R, Falaschi F, Frattoni A, Perani G, Finardi G, et al. Enhanced LDL oxidation in uremic patients: an additional mechanism for accelerated atherosclerosis? Kidney Int 1994;45:876-83.
37. Kelleher J, Humphrey CS, Homer D, Davison AM, Giles GR, Losowsky MS. Vitamin A and its transport proteins in patients with chronic renal failure receiving maintenance haemodialysis and after renal transplantation. Clin Sci (Lond) 1983;65:619-26.
38. Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milzani A. Biomarkers of oxidative damage in human disease. Clin Chem 2006;52:601-23.
39. Boaz M, Matas Z, Biro A, Katzir Z, Green M, Fainaru M, et al. Serum malondialdehyde and prevalent cardiovascular disease in hemodialysis. Kidney Int 1999;56:1078-83.